Lewis S, Chen L, Raghuram V, Khundmiri SJ, Chou C, Yang C, Knepper AM. "SLC-omics" of the kidney: solute transporters along the nephron. Am J Cell Physiol. 2021;321(3):C507-518 doi:10.1152/ajpcell.00197.2021

Bensimon A, Pizzagalli MD, Kartnig F, Dvorak V, Essletzbichler P, Winter GE, Superti-Furfa G. Targeted degradation of SLC transporters reveals amenability of multi-pass transmembrane proteins to ligand-induced proteolysis. Cell Cham Biol. 2020;27(6):728-739.e9.: 10.1016/j.chemibiol.2020.04.003

Navarro GA, Kin YC, Oe Y, Zhang H, Crespo-Masip M, Goodluck HA, Kanoo S, Sanders PW, Broer S, Vallon V. Aristolochic acid-induced nephropathy is attenuated in mice lacking the neutralamino acid transporter B 0 AT1 (Slc6a19). Am J Physiol Renal Physiol. 2022;323(4):F455-F467. doi:10.1152/ajprenal.00181.2022.

Kharin A, Klussmann E. Many kinases for controlling the water channelaquaporin-2. J Physiol. 2023;602(13):3025-3039 doi:10.1113/JP284100.

Chen M, Cai H, Klein JD, Laur O, Chen G. Dexamethasone increases aquaporin-2 protein expression in ex vivo inner medullary collecting duct suspensions. Front Physiol. 2015;6:310. doi:10.3389/fphys.2015.00310

Alkhofash NF, Ali BR: Hartnup disease-causing SLC6A19 mutations lead to B0AT1 aberrant trafficking and ACE2 mis-localisation implicating the endoplasmic reticulum protein quality control. Front Cell Dev Bio 13: 1589534, 2025. doi:10.3389/fcell.2025.1589534.

He L, Zhang Q, Sheng X, Yin J, Yan Y, Wu M, et al. Loss of ARNTL Enhances ER Stress and Apoptosis in CKD Through Disruption of NRF2 Signaling. FASEB J. 2025;39(11):e70715. doi: 10.1096/fj.202403398RRR.

Cheng Y, Kou Y, Wang J, Wang Y, Rong W, Han H, Zhang G. 5-Hydroxytryptamine 4 Receptor Agonist Attenuates Diabetic Enteric Neuropathy through Inhibition of the Receptor-Interacting Protein Kinase 3 Pathway. Am J Pathol. May 2024;194(5):785-795. doi: 10.1016/j.ajpath..2024.01.006.

Auger JP, Zimmermann M, Faas M, Stifel U, Chambers D, Krishnacoumar B, Taudte RV, Grund C, Erdmann G, Scholtysek C, Uderhardt S, Ben Brahim O, Pascual Mate M, Stoll C, Bottcher M, Palumbo-Zerr K, Mangan MSJ, Dzamukova M, Kieler M, Hofmann M, Bluml S, Schabbauer G, Mougiakakos D, Sonnewald U, Hartmann F, Simon D, Kleyer A, Gruneboom A, Finotto S, Latz E, Hofmann J, Schett G, Tuckermann J, Kronke G. Metabolic rewiring promotes anti-inflammatory effects of glucocorticoids. Nature. May 2024;629(8010):184-192.

Sekiguchi Y, Mori M, Maruyama H, Nakao Y, Kikuchi H, Mandai S, Ando F, Susa K, Mori T, Waseda Y, Yoshida S, Fujii Y, Shoda W, Takahashi D, Okazaki R, Ikeda K, Yamada T, Sohara E, Uchida S, Mori Y. The Pathophysiological Mechanism of Beni-koji Choleste-Help or Puberulic Acid–Induced Kidney Injury. Kidney Int Rep. 2026;11(4):103793. doi: 10.1016/j.ekir.2026.103793.

Kramers BJ, Koorevaar IW, van Gastel MDA, van Goor H, Hallows KR, Heerspink HL, Li H, Leonhard WN, Peters DJM, Qiu J, Touw DJ, Gamsevoort RT, Meijer E: Effects of hydrochlorothiazide and metformin on aquaresis and nephroprotection by a vasopressin V2 receptor antagonist in ADPKD: A randomized crossover trial. Clin J Am Soc Nephrol 17: 507-517, 2022
<参考>Jdiaa SS, Mustafa RA, Yu ASL:Treatment of autosomal-dominant polycystic kidney disease. Am J Kidney Dis 85: 491-200, 2025